TScan Therapeutics, Inc. Annual Interest Expense in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
TScan Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2024.
  • TScan Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2024 was $784K, a 7.98% decline year-over-year.
  • TScan Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2024 was $3.65M, a 2.82% decline year-over-year.
  • TScan Therapeutics, Inc. annual Interest Expense for 2024 was $3.65M, a 2.82% decline from 2023.
  • TScan Therapeutics, Inc. annual Interest Expense for 2023 was $3.76M, a 220% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.65M -$106K -2.82% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $3.76M +$2.58M +220% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $1.18M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.